![]() |
|
|
RR Huang, RN Dehaven, AH Cheung, RE Diehl, RA Dixon and CD Strader
Department of Molecular Pharmacology and Biochemistry, Merck, Sharp, and Dohme Research Laboratories, Rahway, New Jersey 07065.
A series of compounds that inhibit the coupling of the alpha 2- adrenergic receptor and the beta 2-adrenergic receptor to the guanine nucleotide-binding proteins (G proteins) Gi and Gs, respectively, have been identified. This inhibition of G protein coupling was detected by the ability of the compounds to reduce the affinity of these receptors for agonists without affecting antagonist affinity. Analysis of the structure-activity relationships of these compounds revealed a requirement for regularly spaced anionic substituents on amphipathic structures for this inhibition to occur. The compounds do not interact at the ligand binding site of the receptor or at the GTP binding site of the G protein. The identification of compounds that can uncouple receptors from G proteins demonstrates the potential for the discovery of small molecule inhibitors of receptor-G protein interactions that act as allosteric antagonists at this site.
This article has been cited by other articles:
![]() |
W.-C. Chung and J. C. Kermode Suramin Disrupts Receptor-G Protein Coupling by Blocking Association of G Protein {alpha} and {beta}{gamma} Subunits J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 191 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Molinari, C. Ambrosio, D. Riitano, M. Sbraccia, M. C. Gro, and T. Costa Promiscuous Coupling at Receptor-Galpha Fusion Proteins. THE RECEPTOR OF ONE COVALENT COMPLEX INTERACTS WITH THE alpha -SUBUNIT OF ANOTHER J. Biol. Chem., April 25, 2003; 278(18): 15778 - 15788. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Christopoulos and T. Kenakin G Protein-Coupled Receptor Allosterism and Complexing Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Benaud, M. Oberst, J. P. Hobson, S. Spiegel, R. B. Dickson, and C.-Y. Lin Sphingosine 1-Phosphate, Present in Serum-derived Lipoproteins, Activates Matriptase J. Biol. Chem., March 15, 2002; 277(12): 10539 - 10546. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Fawzi, D. Macdonald, L. L. Benbow, A. Smith-Torhan, H. Zhang, B. C. Weig, G. Ho, D. Tulshian, M. E. Linder, and M. P. Graziano SCH-202676: An Allosteric Modulator of Both Agonist and Antagonist Binding to G Protein-Coupled Receptors Mol. Pharmacol., January 1, 2001; 59(1): 30 - 37. [Abstract] [Full Text] |
||||
![]() |
M. Waldhoer, E. Bofill-Cardona, G. Milligan, M. Freissmuth, and C. Nanoff Differential Uncoupling of A1 Adenosine and D2 Dopamine Receptors by Suramin and Didemethylated Suramin (NF037) Mol. Pharmacol., May 1, 1998; 53(5): 808 - 818. [Abstract] [Full Text] |
||||
![]() |
J. B. Thompson, S. M. Wade, J. K. Harrison, M. N. Salafranca, and R. R. Neubig Cotransfection of Second and Third Intracellular Loop Fragments Inhibit Angiotensin AT1a Receptor Activation of Phospholipase C in HEK-293 Cells J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 216 - 222. [Abstract] [Full Text] |
||||
![]() |
M. Hohenegger, M. Waldhoer, W. Beindl, B. Boing, A. Kreimeyer, P. Nickel, C. Nanoff, and M. Freissmuth Gsalpha-selective G protein antagonists. PNAS, January 6, 1998; 95(1): 346 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Thomas, M. J. Carson, M. J. Neal, and J. G. Sutcliffe Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide PNAS, December 9, 1997; 94(25): 14115 - 14119. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Fennewald and R. F. Rando Inhibition of High Affinity Basic Fibroblast Growth Factor Binding by Oligonucleotides J. Biol. Chem., September 15, 1995; 270(37): 21718 - 21721. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Rymer and T. A. Good The Role of G Protein Activation in the Toxicity of Amyloidogenic Abeta -(1-40), Abeta -(25-35), and Bovine Calcitonin J. Biol. Chem., January 19, 2001; 276(4): 2523 - 2530. [Abstract] [Full Text] [PDF] |
||||